azomycin has been researched along with Experimental Mammary Neoplasms in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 57 (64.77) | 18.7374 |
1990's | 16 (18.18) | 18.2507 |
2000's | 8 (9.09) | 29.6817 |
2010's | 7 (7.95) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boult, JKR; Collins, DJ; d'Arcy, JA; Jerome, NP; Koh, DM; Leach, MO; Nerurkar, A; Orton, MR; Robinson, SP | 1 |
Adochite, RC; Andreev, OA; Carlin, SD; Guerrieri, RA; Lewis, JS; Moshnikova, A; Reshetnyak, YK | 1 |
Dings, RP; Griffin, RJ; Hardee, ME; Jamshidi-Parsian, A; Koonce, NA; Levy, J; Raleigh, JA; Sharma, S; Vang, KB | 1 |
McPhail, LD; Robinson, SP | 1 |
Busk, M; Horsman, MR; Jakobsen, S; Mortensen, LS; Nordsmark, M; Overgaard, J; Theil, J | 1 |
Fujii, H; Hiraoka, M; Kizaka-Kondoh, S; Kudo, T; Miyano, A; Mutou, Y; Ogawa, K; Ono, M; Saji, H; Ueda, M; Umeda, IO | 1 |
Griffin, RJ; Koonce, NA; Przybyla, BD; Shafirstein, G; Webber, JS | 1 |
Patt, M; Scheunemann, M; Sorger, D; Stöcklin, G | 1 |
Bloomer, WD; Ji, M; Papadopoulou, MV | 1 |
Bentzen, L; Eskola, O; Grönroos, T; Haaparanta, M; Horsman, MR; Keiding, S; Marjamäki, P; Minn, H; Murata, R; Solin, O | 1 |
Kumar, P; McEwan, AJ; McQuarrie, SA; Wiebe, LI; Zhou, A | 1 |
De Bast, M; Gillart, J; Grégoire, V; Labar, D; Mahy, P | 1 |
Mankoff, DA; Rajendran, JG | 1 |
Andratschke, N; Beck, R; Carlsen, JM; Huisman, MC; Lebschi, JA; Machulla, HJ; Picchio, M; Piert, M; Röper, B; Souvatzoglou, M | 1 |
Sinesi, MS; Stone, HB | 1 |
Abe, M; Hamanaka, D; Hiraoka, M; Nishidai, T; Ono, K; Takahashi, M | 1 |
Begg, AC; Terry, NH | 1 |
Tsukiyama, I | 1 |
Rockwell, S | 2 |
Abe, M; Dodo, Y; Nishidai, T; Ono, K; Takahashi, M | 1 |
Mulcahy, RT | 1 |
Brown, DM; Goldfeder, A | 1 |
Irvin, CG; Nierenburg, M; Rockwell, S | 1 |
Yamashita, M | 1 |
Maezawa, H; Mori, T; Murayama, C; Ohizumi, Y | 2 |
Banerjee, R; Goldfeder, A; Mitra, J | 2 |
Denekamp, J; Fowler, JF; Hill, SA; Minchinton, AI; Stratford, MR | 1 |
Lehman, CM; Stewart, JR | 1 |
Chapman, JD; Jette, DC; Wiebe, LI | 1 |
Nielsen, OS; Overgaard, J; Overgaard, M; Pedersen, AK; Timothy, AR | 1 |
Maimonis, P; Michaels, HB; Sedlacek, R; Suit, HD | 1 |
Breur, K; Haveman, J; van den Hoeven, H; van der Schueren, E; Wondergem, J | 1 |
Abe, M; Furunishi, H; Kawanishi, K; Suyama, S; Yabumoto, E; Yamazaki, T | 1 |
Overgaard, J | 1 |
Ash, DV; Smith, MR | 1 |
Conroy, PJ; Passalacqua, W; Sutherland, RM | 1 |
Courdi, A; Malaise, EP | 1 |
Twentyman, PR | 1 |
Begg, AC; Brown, JM; Fu, KK; Hurst, S | 1 |
Tannock, IF | 2 |
Denny, WA; Hay, MP; Lee, HH; Roberts, PB; Wilson, WR | 1 |
Denny, WA; Hay, MP; Moselen, JW; Wilson, WR | 1 |
Cherif, A; Gretzer, MB; Kim, EE; Li, C; Podoloff, DA; Wallace, S; Yang, DJ | 1 |
Hodgkiss, RJ; Parrick, J; Porssa, M; Stratford, MR | 1 |
Abe, M; Oya, N; Sasai, K; Shibamoto, Y; Sugiyama, T | 1 |
Dennis, MF; Hill, SA; Hodgkiss, RJ; Stratford, MR | 1 |
Aboagye, EO; Graham, MA; Kelson, AB; Lewis, AD; Ryan, KJ; Tracy, M; Workman, P | 1 |
Arnold, S; Chaplin, DJ; Collingridge, D; Hill, SA; Horsman, MR; Overgaard, J; Radacic, M; Wood, PJ | 1 |
Cherif, A; Hunter, N; Inoue, T; Kim, EE; Milas, L; Milross, CG; Podoloff, DA; Tansey, W; Wallace, S; Yang, DJ | 1 |
Bloomer, WD; Ji, M; Papadopoulou, MV; Rao, MK | 1 |
Aboagye, EO; Griffiths, JR; Horsman, MR; Lewis, AD; Maxwell, RJ; Tracy, M; Workman, P | 1 |
Hodgkiss, RJ; Webster, L; Wilson, GD | 1 |
Arteel, GE; Chou, SC; Horsman, MR; Raleigh, JA | 1 |
Bergman, J; Eskola, O; Forsback, S; Grönroos, T; Haaparanta, M; Lehtiö, K; Marjamäki, P; Minn, H; Solin, O | 1 |
Fowler, JF | 1 |
Denekamp, J; Flockhart, IR; McNally, NJ; Sheldon, P; Stewart, FA | 1 |
Davies, RW; Hall, WS | 1 |
Macfarlane, W; Sutherland, R | 1 |
Stone, HB | 1 |
Gomer, CJ; Hetzel, FW; Johnson, RJ; Lawrence, G | 1 |
Brown, JM; Suit, HD | 1 |
Berger, A; Brown, DM; Goldfeder, A | 1 |
Milas, L; Stone, HB | 1 |
Bleehen, NM; Honess, DJ; Morgan, JE | 1 |
Denekamp, J; Field, SB; Morris, C | 1 |
Denekamp, J; Field, SB; Harris, SR; Morris, C | 1 |
Adams, GE; Denekamp, J; Fowler, JF | 1 |
Denekamp, J; Harris, SR | 2 |
Stone, HB; Withers, HR | 1 |
Foster, JL; Fowler, JF; Hill, SA; Sheldon, PW | 1 |
Carl, U; Hodgkiss, RJ; Joiner, MC; Kjellen, E; Rojas, A; Wilson, GD | 1 |
Bubley, G; Coleman, CN; Eder, JP; Frei, E; Herman, TS; Holden, SA; Tanaka, J; Teicher, BA | 1 |
Abe, M; Fushiki, M; Iwai, H; Nishimoto, S; Sasai, K; Shibamoto, Y; Suyama, S; Takahashi, M; Yukawa, Y | 1 |
George, KC; Pelzer, T; Streffer, C | 1 |
Griffiths, JR; Maxwell, RJ; Workman, P | 1 |
Abe, M; Hori, H; Inayama, S; Kano, E; Ono, K; Shibamoto, Y; Shibata, T; Takahashi, M | 1 |
Harris, JW; Shrieve, DC | 1 |
Fukuda, H; Hori, H; Inayama, S; Nakajima, T; Onoyama, Y; Sugimoto, K; Tanaka, M | 1 |
Noker, PE; Simpson-Herren, L; Wagoner, SD | 1 |
Overgaard, J; Zachariae, C | 1 |
Fukuda, H; Kida, A; Nakajima, T; Onoyama, Y; Sakashita, M; Tanaka, M; Tsumura, M | 1 |
Foster, JL; Fowler, JF; Sheldon, PW | 1 |
Bryan, GT; Cohen, SM; Crovetti, AJ; Ertürk, E; Von Esch, AM | 1 |
88 other study(ies) available for azomycin and Experimental Mammary Neoplasms
Article | Year |
---|---|
Characterisation of fibrosis in chemically-induced rat mammary carcinomas using multi-modal endogenous contrast MRI on a 1.5T clinical platform.
Topics: Animals; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Fibrosis; Humans; Mammary Neoplasms, Experimental; Necrosis; Nitroimidazoles; Platelet Endothelial Cell Adhesion Molecule-1; Rats, Sprague-Dawley | 2018 |
Targeting breast tumors with pH (low) insertion peptides.
Topics: Animals; Blood Glucose; Cell Line, Tumor; Deoxyglucose; Drug Delivery Systems; Female; Hydrogen-Ion Concentration; Immunohistochemistry; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactates; Mammary Neoplasms, Animal; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Transgenic; Microscopy, Fluorescence; Neoplasm Transplantation; Nitroimidazoles; Peptides; Time Factors | 2014 |
Targeting Artificial Tumor Stromal Targets for Molecular Imaging of Tumor Vascular Hypoxia.
Topics: Animals; Biomarkers, Tumor; Blood Vessels; Cell Hypoxia; Cell Line, Tumor; Contrast Media; Female; Imaging, Three-Dimensional; Mammary Neoplasms, Experimental; Mice; Microbubbles; Molecular Imaging; Nitroimidazoles; Stromal Cells; Ultrasonography | 2015 |
Intrinsic susceptibility MR imaging of chemically induced rat mammary tumors: relationship to histologic assessment of hypoxia and fibrosis.
Topics: Animals; Biomarkers, Tumor; Carbon Dioxide; Female; Fibrosis; Hypoxia; Keratin-14; Linear Models; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Methylnitrosourea; Necrosis; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Rats; Rats, Wistar | 2010 |
Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study.
Topics: Animals; Cell Hypoxia; Disease Models, Animal; Electrodes; Female; Fluorine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Nitroimidazoles; Positron-Emission Tomography; Prognosis; Radiation Tolerance | 2011 |
Evaluation of [125I]IPOS as a molecular imaging probe for hypoxia-inducible factor-1-active regions in a tumor: comparison among single-photon emission computed tomography/X-ray computed tomography imaging, autoradiography, and immunohistochemistry.
Topics: Animals; Autoradiography; Biotin; Female; Fluorescent Antibody Technique, Direct; Hypoxia-Inducible Factor 1, alpha Subunit; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Proteins; Nitroimidazoles; Radiopharmaceuticals; Recombinant Fusion Proteins; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2011 |
Conductive thermal ablation of 4T1 murine breast carcinoma reduces severe hypoxia in surviving tumour.
Topics: Animals; Combined Modality Therapy; Female; Hyperthermia, Induced; Hypoxia; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitroimidazoles; Radiation-Sensitizing Agents | 2012 |
Adduct of 2-[18F]FDG and 2-nitroimidazole as a putative radiotracer for the detection of hypoxia with PET: synthesis, in vitro- and in vivo-characterization.
Topics: Animals; Carcinoma 256, Walker; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; HeLa Cells; Humans; In Vitro Techniques; Mammary Neoplasms, Experimental; Nitroimidazoles; Radiochemistry; Radiopharmaceuticals; Rats; Rats, Wistar; Tomography, Emission-Computed; Tumor Cells, Cultured | 2002 |
Synergistic interaction between cyclophosphamide or paclitaxel and the bioreductive compound NLCPQ-1, in vivo.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Drug Synergism; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitroimidazoles; Paclitaxel; Quinolines; Tumor Cells, Cultured | 2003 |
Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
Topics: Animals; Cell Hypoxia; Female; Fluorine Radioisotopes; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Mice; Misonidazole; Nitroimidazoles; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2004 |
[131I]Iodoazomycin arabinoside for low-dose-rate isotope radiotherapy: radiolabeling, stability, long-term whole-body clearance and radiation dosimetry estimates in mice.
Topics: Animals; Cell Hypoxia; Cell Proliferation; Female; Humans; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Nitroimidazoles; Radioimmunotherapy; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Tetrazolium Salts; Thiazoles; Tissue Distribution; Tumor Cells, Cultured | 2005 |
Detection of tumour hypoxia: comparison between EF5 adducts and [18F]EF3 uptake on an individual mouse tumour basis.
Topics: Animals; Cell Hypoxia; Drug Evaluation, Preclinical; Etanidazole; Fibrosarcoma; Fluorescent Antibody Technique; Hydrocarbons, Fluorinated; Male; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Mice; Mice, Inbred C3H; Nitroimidazoles; Organ Specificity; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2006 |
Beyond detection: novel applications for PET imaging to guide cancer therapy.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Mammary Neoplasms, Experimental; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 2007 |
Pretreatment 18F-FAZA PET predicts success of hypoxia-directed radiochemotherapy using tirapazamine.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Cell Line, Tumor; Combined Modality Therapy; Female; Fluorine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tirapazamine; Transplantation, Heterologous; Triazines; Whole Body Imaging | 2007 |
Testing of new hypoxic cell sensitizers in vivo.
Topics: Animals; Drug Evaluation, Preclinical; Etanidazole; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1982 |
[Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
Topics: Animals; Etanidazole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1983 |
Modification of stromal radiosensitivity by misonidazole and WR-2721.
Topics: Adenocarcinoma; Amifostine; Animals; Connective Tissue; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Tolerance | 1983 |
[Combined use of amifostine and misonidazole in experimental radiotherapy].
Topics: Amifostine; Animals; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Radiation-Protective Agents | 1983 |
Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Mitomycin; Mitomycins; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Time Factors | 1984 |
[The effect of diethyl maleate (DEM) on the radiosensitization by misonidazole (MISO) in experimental animal tumors].
Topics: Animals; Drug Synergism; Maleates; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
Topics: Aerobiosis; Animals; Cell Line; Cell Survival; Kinetics; Lomustine; Mammary Neoplasms, Experimental; Mice; Misonidazole; Nitroimidazoles; Oxygen | 1984 |
Response of an experimental mammary carcinoma to fractionated X-irradiation with misonidazole and microwave hyperthermia.
Topics: Adenocarcinoma; Animals; Combined Modality Therapy; Diathermy; Female; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Enhancement of artificial lung metastases by misonidazole.
Topics: Animals; Cell Line; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
Topics: Animals; Cell Line; Combined Modality Therapy; Female; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles | 1984 |
The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Topics: Anaerobiosis; Animals; Combined Modality Therapy; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
Polarographic measurement of misonidazole in mouse mammary tumors.
Topics: Animals; Half-Life; Hypoxia; In Vitro Techniques; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Polarography; Tissue Distribution | 1984 |
Sister chromatid exchanges and chromosome aberrations induced by radiosensitizing agents in bone marrow cells of treated tumor-bearing mice.
Topics: Animals; Bone Marrow; Cell Line; Chromosome Aberrations; Crossing Over, Genetic; Hot Temperature; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Microwaves; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiotherapy Dosage; Sister Chromatid Exchange | 1983 |
Radiosensitization of a mouse tumour by Ro 03-8799: acute and protracted administration.
Topics: Animals; Injections, Intraperitoneal; Mammary Glands, Animal; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents | 1983 |
In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
Topics: Animals; Drug Evaluation, Preclinical; Female; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Temperature; Time Factors | 1983 |
Synthesis and in vivo studies of the radiosensitizer 4-[82Br]bromomisonidazole.
Topics: Animals; Bromine; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Radioisotopes; Radionuclide Imaging; Tissue Distribution | 1983 |
Combined effects of misonidazole, microwave hyperthermia, and X-rays on the in vivo sister chromatid exchanges and chromosomal abnormalities of the dbrB tumor and on the survival of its host.
Topics: Adenocarcinoma; Animals; Chromosome Aberrations; Crossing Over, Genetic; Female; Hot Temperature; Karyotyping; Mammary Neoplasms, Experimental; Mice; Microwaves; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiotherapy Dosage; Sister Chromatid Exchange; Time Factors; X-Rays | 1983 |
A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Misonidazole; Nimorazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1982 |
Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
Topics: Animals; Carcinoma, Squamous Cell; Female; Hyperbaric Oxygenation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Skin | 1981 |
The influence of misonidazole on the radiation response of murine tumors of different size: possible artifacts caused by pentobarbital sodium anesthesia.
Topics: Adenocarcinoma; Anesthesia; Animals; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Pentobarbital; Radiation-Protective Agents | 1981 |
[Radiosensitization of C3H/He mammary carcinoma by administration of hyperthermia and/or of misonidazole (author's transl)].
Topics: Animals; Female; Hot Temperature; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1981 |
Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
Topics: Animals; Dose-Response Relationship, Drug; Female; Hot Temperature; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation Tolerance; Skin; Time Factors | 1980 |
Causes of apparent low levels of misonidazole in human tumours.
Topics: Adipose Tissue; Animals; Brain Neoplasms; Humans; In Vitro Techniques; Liver Neoplasms; Mammary Neoplasms, Experimental; Mice; Misonidazole; Muscles; Neoplasms; Nitroimidazoles; Rats | 1980 |
Misonidazole cytotoxicity in vivo: a comparison of large single doses with smaller doses and extended contact of the drug with tumor cells.
Topics: Animals; Body Temperature; Dose-Response Relationship, Drug; Infusions, Parenteral; Injections, Intraperitoneal; Kinetics; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Time Factors; Transplantation, Homologous | 1980 |
Effect of size of lymph node metastases on the radiation response: influence of misonidazole.
Topics: Animals; Cell Count; Female; Gamma Rays; Injections, Intraperitoneal; Lymph Nodes; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Misonidazole; Nitroimidazoles; Organ Size; Time Factors | 1980 |
The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; In Vitro Techniques; Mammary Neoplasms, Experimental; Mechlorethamine; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1980 |
The effects of misonidazole during continuous low dose rate irradiation.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Half-Life; Injections, Intraperitoneal; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Topics: Animals; Body Weight; Doxorubicin; Drug Therapy, Combination; Fibrosarcoma; Fluorouracil; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Methotrexate; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Topics: Animals; Body Weight; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Fibrosarcoma; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Hypoxia; Cell Line; Chemical Phenomena; Chemistry, Physical; Cricetinae; Cricetulus; Heterocyclic Compounds; Humans; Mammary Neoplasms, Experimental; Melanoma; Mice; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Solubility; Structure-Activity Relationship; Water | 1995 |
N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
Topics: Aerobiosis; Animals; Antineoplastic Agents; Cell Division; Cell Hypoxia; Cell Line; Cell Survival; Cricetinae; Cricetulus; Mammary Neoplasms, Experimental; Nitroimidazoles; Oxidation-Reduction; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.
Topics: Animals; Autoradiography; Cell Hypoxia; Contrast Media; Female; Fluorine Radioisotopes; Male; Mammary Neoplasms, Experimental; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Rabbits; Rats; Rats, Inbred F344; Tissue Distribution; Tomography, Emission-Computed | 1995 |
Bioreductive markers for hypoxic cells: 2-nitroimidazoles with biotinylated 1-substituents.
Topics: Animals; Avidin; Bacterial Proteins; Biomarkers; Biotin; Cell Hypoxia; Chromatography, High Pressure Liquid; Flow Cytometry; Fluorescein-5-isothiocyanate; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Nitroimidazoles; Oxidation-Reduction; Oxygen; Streptavidin; Tumor Cells, Cultured | 1994 |
In vivo radiosensitization efficacy of KU-2285 and etanidazole at clinically relevant low radiation doses.
Topics: Animals; Cell Division; Cell Line; Chromosome Aberrations; Dose-Response Relationship, Radiation; Etanidazole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Micronucleus Tests; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Tumor Cells, Cultured | 1993 |
Pharmacokinetics and binding of the bioreductive probe for hypoxia, NITP: effect of route of administration.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Animals; beta-Cyclodextrins; Cell Hypoxia; Chromatography, High Pressure Liquid; Cyclodextrins; Dimethyl Sulfoxide; Drug Administration Routes; Flow Cytometry; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Nitroimidazoles; Peanut Oil; Plant Oils; Radiation-Sensitizing Agents; Theophylline | 1995 |
The pharmacokinetics, bioavailability and biodistribution in mice of a rationally designed 2-nitroimidazole hypoxia probe SR-4554.
Topics: Animals; Biological Availability; Brain; Cell Hypoxia; Female; Liver; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Molecular Probes; Neoplasm Transplantation; Nitroimidazoles; Tissue Distribution | 1996 |
Effect of nitro-L-arginine on blood flow, oxygenation and the activity of hypoxic cell cytotoxins in murine tumours.
Topics: Animals; Antineoplastic Agents; Cell Hypoxia; Female; Hyperthermia, Induced; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred CBA; Nitroarginine; Nitroimidazoles; Regional Blood Flow; Sarcoma, Experimental | 1996 |
Evaluation of [131I]iodoerythronitroimidazole as a predictor for the radiosensitizing effect.
Topics: Animals; Cell Transplantation; Female; Iodine Radioisotopes; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Predictive Value of Tests; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Cells, Cultured | 1996 |
9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1): a novel DNA-affinic bioreductive agent as chemosensitizer. I.
Topics: Animals; Antineoplastic Agents; Cell Survival; Cells, Cultured; Cisplatin; Cricetinae; Cricetulus; DNA Adducts; DNA, Neoplasm; Drug Synergism; Female; Mammary Neoplasms, Experimental; Melphalan; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitroimidazoles; Quinolines; Tumor Cells, Cultured | 1997 |
The relationship between tumour oxygenation determined by oxygen electrode measurements and magnetic resonance spectroscopy of the fluorinated 2-nitroimidazole SR-4554.
Topics: Animals; Carcinoma; Cell Hypoxia; Fluorine Radioisotopes; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Molecular Probes; Nitroimidazoles; Oxygen | 1998 |
Measurement of hypoxia in vivo using a 2-nitroimidazole (NITP).
Topics: Adenocarcinoma; Animals; Cell Hypoxia; Female; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Mammary Neoplasms, Experimental; Mice; Nitroimidazoles; Oxygen; Respiration; Sarcoma, Experimental; Theophylline | 1997 |
Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors.
Topics: Animals; Biomarkers; Cell Hypoxia; Electrodes; Female; Immunohistochemistry; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1999 |
Pharmacokinetics of [18F]FETNIM: a potential marker for PET.
Topics: Animals; Dogs; Female; Fluorine Radioisotopes; Head and Neck Neoplasms; Humans; Hypoxia; Mammary Neoplasms, Experimental; Nitroimidazoles; Rats; Rats, Sprague-Dawley; Tissue Distribution; Tomography, Emission-Computed | 2001 |
Developments in radiotherapy other than heavy particle beams.
Topics: Animals; Brain Neoplasms; Energy Transfer; Fast Neutrons; Female; Glioblastoma; Hot Temperature; Humans; Mammary Neoplasms, Experimental; Metronidazole; Mice; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; Radiotherapy, High-Energy; Urinary Bladder Neoplasms; Uterine Cervical Neoplasms; X-Rays | 1977 |
Radiosensitization by misonidazole (Ro 07-0582). The importance of timing and tumor concentration of sensitizer.
Topics: Animals; Female; Fibrosarcoma; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Osteosarcoma; Oxygen; Radiation-Sensitizing Agents; Time Factors; Transplantation, Isogeneic | 1978 |
Oxygen cathode measurements and radiation response in tumour-bearing mice treated with misonidazole.
Topics: Adenocarcinoma; Animals; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Skin; Time Factors | 1978 |
Cytotoxicity of radiosensitizers in multicell spheroids: combination treatment with hyperthermia.
Topics: Animals; Cell Survival; Cells, Cultured; Hot Temperature; Mammary Neoplasms, Experimental; Models, Biological; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1978 |
Enhancement of local tumour control by misonidazole and hyperthermia.
Topics: Animals; Female; Hot Temperature; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nitroimidazoles; Radiation-Sensitizing Agents | 1978 |
Cytotoxic and radiosensitizing effects of hypoxic cell sensitizers on EMT6 mouse mammary tumour cells in vivo and in vitro.
Topics: Animals; Cell Survival; In Vitro Techniques; Lethal Dose 50; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitroimidazoles; Oxygen; Pyrroles; Radiation-Sensitizing Agents; Thiazoles | 1978 |
The demonstration of in vivo misonidazole tumour toxicity using post radiation hypoxia.
Topics: Animals; Cell Survival; Female; Mammary Neoplasms, Experimental; Mice; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Time Factors | 1978 |
Relative efficacy of high-pressure oxygen and misonidazole to reduce TCD50 of a mouse mammary carcinoma.
Topics: Animals; Hyperbaric Oxygenation; Lethal Dose 50; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles | 1979 |
Enhancement of radioresponse of a mouse mammary carcinoma to combined treatments with hyperthermia and radiosensitizer misonidazole.
Topics: Adenocarcinoma; Animals; Hot Temperature; Male; Mammary Neoplasms, Experimental; Mice; Misonidazole; Nitroimidazoles; Radiation Tolerance; Remission, Spontaneous; Time Factors; X-Rays | 1979 |
Modification of radiation responses of murine tumors by misonidazole (Ro 07-0582), host immune capability, and Corynebacterium parvum.
Topics: Animals; Dose-Response Relationship, Radiation; Female; Hypoxia; Immunity; Immunotherapy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nitroimidazoles; Oxygen; Propionibacterium acnes; Sarcoma, Experimental | 1978 |
Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.
Topics: Animals; Body Temperature; Cell Survival; Hot Temperature; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Nitroimidazoles; Radiation-Sensitizing Agents; Time Factors | 1977 |
The response of a transplantable tumor to fractionated irradiation. III. Fast neutrons plus the radiosensitizer Ro-07-0582.
Topics: Animals; Dose-Response Relationship, Radiation; Fast Neutrons; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Nitroimidazoles; Radiation-Sensitizing Agents | 1977 |
The response of a transplantable tumor to fractionated irradiation. II. Fast neutrons.
Topics: Animals; Dose-Response Relationship, Radiation; Fast Neutrons; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; X-Rays | 1976 |
Radiosensitizers of hypoxic cells in solid tumors.
Topics: Animals; Cells, Cultured; Cricetinae; Dose-Response Relationship, Drug; Fast Neutrons; Mammary Neoplasms, Experimental; Metronidazole; Mice; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Oxygen Consumption; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1976 |
Tests of two electron-affinic radiosensitizers in vivo using regrowth of an experimental carcinoma.
Topics: Animals; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Metronidazole; Mice; Mice, Inbred CBA; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; X-Rays | 1975 |
Letter: Enhancement of the radioresponse of a murine tumour by a nitroimidazone.
Topics: Animals; Hyperbaric Oxygenation; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nitroimidazoles; Radiation-Sensitizing Agents | 1975 |
The response of a transplantable tumor to fractionated irradiation. 1. X rays and the hypoxic cell radiosensitizer Ro-07-0582.
Topics: Animals; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage; X-Ray Therapy | 1976 |
Radiosensitization of C3H mouse mammary tumours using fractionated doses of x rays with the drug Ro-07-0582.
Topics: Animals; Dose-Response Relationship, Radiation; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Nitroimidazoles; Radiation Effects; Radiation-Sensitizing Agents; Radiotherapy Dosage; Skin | 1976 |
Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys.
Topics: Administration, Inhalation; Animals; Carbon Dioxide; Cell Hypoxia; Kidney; Mammary Neoplasms, Experimental; Mice; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Radiation Injuries, Experimental; Radiation-Sensitizing Agents; Skin | 1992 |
Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Carbon Dioxide; Carboplatin; Carmustine; Cell Survival; Colony-Forming Units Assay; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Etanidazole; Fibrosarcoma; Flow Cytometry; Fluorocarbons; Hydroxyethyl Starch Derivatives; Mammary Neoplasms, Experimental; Melphalan; Mice; Nitroimidazoles; Organoplatinum Compounds; Oxygen; Radiation-Sensitizing Agents; Thiotepa | 1991 |
In vivo radiosensitizing activity of a new fluorinated hypoxic cell radiosensitizer, KU-2285, in combination with radiation dose fractionation.
Topics: Animals; Carcinoma, Squamous Cell; Cell Survival; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1991 |
Combined effects of X rays, Ro 03-8799, and hyperthermia on growth, necrosis, and cell proliferation in a mouse tumor.
Topics: Adenocarcinoma; Animals; Combined Modality Therapy; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1989 |
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo.
Topics: Animals; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |
An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
Topics: Animals; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tetrazoles | 1986 |
The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers.
Topics: Animals; Cell Line; Cell Survival; Cells, Cultured; Etanidazole; Female; Mammary Neoplasms, Experimental; Mice; Misonidazole; Nitroimidazoles; Oxygen; Radiation Tolerance; Radiation-Sensitizing Agents; Rats; Sulfhydryl Compounds; X-Rays | 1985 |
[Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
Topics: Animals; Chemical Phenomena; Chemistry; Drug Evaluation; Lethal Dose 50; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Rabbits; Radiation-Sensitizing Agents | 1988 |
Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.
Topics: Adenocarcinoma; Animals; Female; Lissamine Green Dyes; Mammary Neoplasms, Experimental; Melphalan; Metronidazole; Mice; Misonidazole; Nitroimidazoles; Time Factors | 1987 |
Interactions of radiation, cyclophosphamide and nimorazole in a C3H mammary carcinoma in vivo.
Topics: Animals; Combined Modality Therapy; Cyclophosphamide; Mammary Neoplasms, Experimental; Mice; Nimorazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1986 |
[Effect of the hypoxic cell radiosensitizer,a dinitroimidazole derivative, on murine tumors].
Topics: Animals; Lethal Dose 50; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Rabbits; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1986 |
Radiosensitization of C3H mouse mammary tumours by a 2-nitroimidazole drug.
Topics: 1-Propanol; Animals; Female; Hypoxia; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Neoplasm Transplantation; Nitroimidazoles; Oxygen Consumption; Preventive Medicine; Propanols; Radiation-Sensitizing Agents; Radiotherapy Dosage; Transplantation, Homologous | 1974 |
Carcinogenicity of 5-nitrofurans, 5-nitroimidazoles, 4-nitrobenzenes, and related compounds.
Topics: Adenocarcinoma; Animals; Benzene Derivatives; Carcinogens; Chemical Phenomena; Chemistry; Diet; Female; Kidney Neoplasms; Leukemia, Experimental; Leukemia, Lymphoid; Mammary Neoplasms, Experimental; Neoplasms, Experimental; Nitrobenzenes; Nitrofurans; Nitroimidazoles; Rats | 1973 |